On January 19, 2023, Leone Patterson notified Eliem Therapeutics, Inc. (Eliem, or the Company) of her decision to resign from the Board of Directors of the Company, effective immediately. In connection with Ms. Patterson's resignation from the Board, the Board (i) decreased the authorized number of directors on the Board from seven to six and (ii) reconstituted the composition of its Audit Committee and Nominating and Corporate Governance Committee. The Audit Committee now consists of Adam Rosenberg (Chairperson), Simon Tate and Judith Dunn.

The Nominating and Corporate Governance Committee now consists of Simon Tate (Chairperson) and Liam Ratcliffe.